SEC Form D private-offering filing

NK-One Therapeutics, Inc.

A new SEC Form D private-offering notice from Wayne, PA, a $310,000 filer-stated offering target in Biotech. The source filing is one click away.

NK-One Therapeutics, Inc. site↗ Verified via SEC Form D

Biotechnology company developing a substance P saporin based treatment platform for refractory cancer pain.

Filed 2026-04-27Filed to raise $310,000First money in 2026-03-04Raised so far $290,000HQ (as filed) Wayne, PASector Biotech Stage (inferred) Pre-seedCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified nk1thera.com↗Named in the filing 2 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.